LunarCrush LLM | creator/twitter::1340292496937644033/posts

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@TaxiBiotech](/creator/twitter/TaxiBiotech)
"🚨 Another NASDAQ BIO chasing BTC BITCOIN Desperate moves are spreading across this sector. What do you think Profusa ( $PFSA ) secures a $100M equity line with Ascent to launch a Bitcoin treasury strategy 🪙 ✅ Theyll issue shares maintain a $5M cash buffer and deploy the rest to buy Bitcoin; which could later be used to repay debt if needed"  
![@TaxiBiotech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1340292496937644033.png) [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1947346305174671645) 2025-07-21 17:21:53 UTC XXX followers, XXX engagements


"🚨📅 July 19: $LXRX Lexicon to present a poster at ASPN 2025 on pilavapadin (LX9211) for diabetic neuropathic pain 🧠 ⚠ Last time they presented LX9211 data the stock dropped over XX% due to lack of statistical significance. 📈 It later rebounded after the $NVO deal 🔍 Poster title: Listening to Patients with Diabetic Peripheral Neuropathic Pain: Insights from a Patient Survey to Inform Advanced Clinical Development of Pilavapadin 📌 With that title. I THINK no new clinical data is coming. Just a patient survey to guide future development More qualitative than clinical Stock down X% today"  
![@TaxiBiotech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1340292496937644033.png) [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1946256686223601960) 2025-07-18 17:12:08 UTC XXX followers, XXX engagements


"💉💸 Weight loss drugs: Caution How do they work Risks benefits worth it Open debate. 👉 +Obesity business: Lilly $LLY / Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR 🚕 Watch on @TaxiBiotech"  
![@TaxiBiotech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1340292496937644033.png) [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1944105082682806689) 2025-07-12 18:42:26 UTC XXX followers, XXX engagements


"$MESO Mesoblasts Ryoncil (remestemcel-L) commercial launch recap: First & only FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease $13.2M in Q2 gross sales (Mar 28Jun 30) $1.6M in royalties from TEMCELL sales in Japan Now covered by Medicare/Medicaid 7-year orphan drug exclusivity + 12-year BLA protection XX US transplant centers onboarded targeting XX 🏥 #Biotech #CellTherapy"  
![@TaxiBiotech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1340292496937644033.png) [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1946079510169829826) 2025-07-18 05:28:06 UTC XXX followers, XXX engagements


"🧪 Yesterday was Crinetics $CRNX #RDInvestorDay. They presented preclinical programs and candidates either in phase 1/2 or about to submit new INDs. Lets walk through what they shared. 👇 Thread:"  
![@TaxiBiotech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1340292496937644033.png) [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1938536489354179032) 2025-06-27 09:54:49 UTC XXX followers, XXX engagements


"#PDUFA #FDA approval days for August: XX $LENZ LNZ100 presbyopia XX $PHRRF.OB KETAMINE (RESUB). Anesthesia pain. XX $INSM BRENSOCATIB. non-CF bronchiectasis XX $TNXP TNX-102 SL. Fibromyalgia XX $JAZZ / $CMRX DORDAPRIVONE. H3 K27M-Mutant diffuse glioma XX $RARE / $ABEO UX111 AAV. Sanfilippo XX $PTCT VATIQUINONE. children and adults Friedreich's ataxia XX $REGN / BAYER EYLEA HD. Macular edema XX $IONS DONIDALORSEN. Angioedema +12yo XX $PGEN PRGN-2012. Respiratory papillomatosis XX $TLX TLX250-CDx. Cancer PET imaging XX $OTLK ONS-5010 (RESUB). Macular degeneration XX $TVTX $LGND FILSPARI."  
![@TaxiBiotech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1340292496937644033.png) [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1947207359270363208) 2025-07-21 08:09:46 UTC XXX followers, XXX engagements


"💉💸 Weight loss drugs: Caution How do they work Risks benefits worth it Open debate. 👉 +Obesity business: Lilly $LLY / Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR 🚕@TaxiBiotech"  
![@TaxiBiotech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1340292496937644033.png) [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1944635944893858203) 2025-07-14 05:51:53 UTC XXX followers, 2244 engagements


"I-Mab $IMAB 🧬 Ph1b dose escalation: givastomig (Claudin18.2 4-1BB bispecific) + nivolumab + mFOLFOX6 in 1stLine gastric cancer ✅ ORR: XX% (13/18); XX% (10/12) at expansion dose 🧬 Responses seen even with low PD-L1/CLDN18.2 broader reach 🩺 Mostly Gr12 TRAEs. X pt (5.6%) Gr3 transaminase 📍 ESMO GI 2025 (Tue 8th) #Biotech #IO #Bispecifics #ESMOGI"  
![@TaxiBiotech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1340292496937644033.png) [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1940456762756288748) 2025-07-02 17:05:18 UTC XXX followers, XXX engagements


"#PDUFA #FDA approval days for September: XX $AXGN AVANCE NERVE GRAFT. Surgical repair. XX $AGIO PYRUKYND. Anemia for PK deficiency in a/b-thalassemia. XX $BCRX ORLADEYO. Hereditary angioedema +2yo. XX $SRKK APITEGROMAB. Spinal muscular atrophy. XX $IONS $BIIB SPINRAZA. Higher dose for spinal muscular atrophy. XX $CRNX PALTUSOTINE. Acromegaly. XX $RPRX AFICAMTEN. Obstructive hypertrophic cardiomyopathy. XX $SNY TOLEBRUTINIB. Multiple sclerosis. XX $FBIO CUTX-101. Menkes disease. Late Sept $OMER NARSOPLIMAB. Transplant-associated thrombotic microangiopathy. source:"  
![@TaxiBiotech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1340292496937644033.png) [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1947239254444171571) 2025-07-21 10:16:30 UTC XXX followers, XXX engagements


"💉💸 Weight loss drugs: Caution How do they work Risks benefits worth it Open debate 👉 + Obesity STOCKS: Lilly $LLY and Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR 🚕 Watch on @TaxiBiotech"  
![@TaxiBiotech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1340292496937644033.png) [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1944104848695136610) 2025-07-12 18:41:30 UTC XXX followers, XXX engagements


"ProMis Neurosciences $PMN 🚨 FDA grants Fast Track to PMN310 for #Alzheimer🧠 PMN310 Targets only toxic soluble amyloid-beta sparing normal A and plaques. Fewer side effects more precision. #biotech #Neuroscience"  
![@TaxiBiotech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1340292496937644033.png) [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1947343360856911992) 2025-07-21 17:10:11 UTC XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@TaxiBiotech "🚨 Another NASDAQ BIO chasing BTC BITCOIN Desperate moves are spreading across this sector. What do you think Profusa ( $PFSA ) secures a $100M equity line with Ascent to launch a Bitcoin treasury strategy 🪙 ✅ Theyll issue shares maintain a $5M cash buffer and deploy the rest to buy Bitcoin; which could later be used to repay debt if needed"
@TaxiBiotech on X 2025-07-21 17:21:53 UTC XXX followers, XXX engagements

"🚨📅 July 19: $LXRX Lexicon to present a poster at ASPN 2025 on pilavapadin (LX9211) for diabetic neuropathic pain 🧠 ⚠ Last time they presented LX9211 data the stock dropped over XX% due to lack of statistical significance. 📈 It later rebounded after the $NVO deal 🔍 Poster title: Listening to Patients with Diabetic Peripheral Neuropathic Pain: Insights from a Patient Survey to Inform Advanced Clinical Development of Pilavapadin 📌 With that title. I THINK no new clinical data is coming. Just a patient survey to guide future development More qualitative than clinical Stock down X% today"
@TaxiBiotech on X 2025-07-18 17:12:08 UTC XXX followers, XXX engagements

"💉💸 Weight loss drugs: Caution How do they work Risks benefits worth it Open debate. 👉 +Obesity business: Lilly $LLY / Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR 🚕 Watch on @TaxiBiotech"
@TaxiBiotech on X 2025-07-12 18:42:26 UTC XXX followers, XXX engagements

"$MESO Mesoblasts Ryoncil (remestemcel-L) commercial launch recap: First & only FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease $13.2M in Q2 gross sales (Mar 28Jun 30) $1.6M in royalties from TEMCELL sales in Japan Now covered by Medicare/Medicaid 7-year orphan drug exclusivity + 12-year BLA protection XX US transplant centers onboarded targeting XX 🏥 #Biotech #CellTherapy"
@TaxiBiotech on X 2025-07-18 05:28:06 UTC XXX followers, XXX engagements

"🧪 Yesterday was Crinetics $CRNX #RDInvestorDay. They presented preclinical programs and candidates either in phase 1/2 or about to submit new INDs. Lets walk through what they shared. 👇 Thread:"
@TaxiBiotech on X 2025-06-27 09:54:49 UTC XXX followers, XXX engagements

"#PDUFA #FDA approval days for August: XX $LENZ LNZ100 presbyopia XX $PHRRF.OB KETAMINE (RESUB). Anesthesia pain. XX $INSM BRENSOCATIB. non-CF bronchiectasis XX $TNXP TNX-102 SL. Fibromyalgia XX $JAZZ / $CMRX DORDAPRIVONE. H3 K27M-Mutant diffuse glioma XX $RARE / $ABEO UX111 AAV. Sanfilippo XX $PTCT VATIQUINONE. children and adults Friedreich's ataxia XX $REGN / BAYER EYLEA HD. Macular edema XX $IONS DONIDALORSEN. Angioedema +12yo XX $PGEN PRGN-2012. Respiratory papillomatosis XX $TLX TLX250-CDx. Cancer PET imaging XX $OTLK ONS-5010 (RESUB). Macular degeneration XX $TVTX $LGND FILSPARI."
@TaxiBiotech on X 2025-07-21 08:09:46 UTC XXX followers, XXX engagements

"💉💸 Weight loss drugs: Caution How do they work Risks benefits worth it Open debate. 👉 +Obesity business: Lilly $LLY / Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR 🚕@TaxiBiotech"
@TaxiBiotech on X 2025-07-14 05:51:53 UTC XXX followers, 2244 engagements

"I-Mab $IMAB 🧬 Ph1b dose escalation: givastomig (Claudin18.2 4-1BB bispecific) + nivolumab + mFOLFOX6 in 1stLine gastric cancer ✅ ORR: XX% (13/18); XX% (10/12) at expansion dose 🧬 Responses seen even with low PD-L1/CLDN18.2 broader reach 🩺 Mostly Gr12 TRAEs. X pt (5.6%) Gr3 transaminase 📍 ESMO GI 2025 (Tue 8th) #Biotech #IO #Bispecifics #ESMOGI"
@TaxiBiotech on X 2025-07-02 17:05:18 UTC XXX followers, XXX engagements

"#PDUFA #FDA approval days for September: XX $AXGN AVANCE NERVE GRAFT. Surgical repair. XX $AGIO PYRUKYND. Anemia for PK deficiency in a/b-thalassemia. XX $BCRX ORLADEYO. Hereditary angioedema +2yo. XX $SRKK APITEGROMAB. Spinal muscular atrophy. XX $IONS $BIIB SPINRAZA. Higher dose for spinal muscular atrophy. XX $CRNX PALTUSOTINE. Acromegaly. XX $RPRX AFICAMTEN. Obstructive hypertrophic cardiomyopathy. XX $SNY TOLEBRUTINIB. Multiple sclerosis. XX $FBIO CUTX-101. Menkes disease. Late Sept $OMER NARSOPLIMAB. Transplant-associated thrombotic microangiopathy. source:"
@TaxiBiotech on X 2025-07-21 10:16:30 UTC XXX followers, XXX engagements

"💉💸 Weight loss drugs: Caution How do they work Risks benefits worth it Open debate 👉 + Obesity STOCKS: Lilly $LLY and Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR 🚕 Watch on @TaxiBiotech"
@TaxiBiotech on X 2025-07-12 18:41:30 UTC XXX followers, XXX engagements

"ProMis Neurosciences $PMN 🚨 FDA grants Fast Track to PMN310 for #Alzheimer🧠 PMN310 Targets only toxic soluble amyloid-beta sparing normal A and plaques. Fewer side effects more precision. #biotech #Neuroscience"
@TaxiBiotech on X 2025-07-21 17:10:11 UTC XXX followers, XXX engagements